'Health Care Quality Indicators - Hospital'

The most common grade 3/4 non-hematologic adverse events (> 5%) were pneumonia, hypertension, atrial fibrillation, sinusitis, skin infection, dehydration and musculoskeletal pain. ... Treatment can improve median survival rates to ~ 5 years. It is estimated that 15,720 adults will be diagnosed with CLL in 2014 and ~ 4600 will succumb to the ... ................
................